Cite
HARVARD Citation
Ortí, G. et al. (2022). Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia. Leukemia research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ortí, G. et al. (2022). Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia. Leukemia research. p. . [Online].